The deception effect of FDA counteracting amplitude-comparison monopulse reconnaissance

EURASIP Journal on Advances in Signal Processing

卷:2022

Junwei Xie¹  Jiaang Ge¹ 

[1] Air and Missile Defense College, Air Force Engineering University;

关键词: Frequency diverse array (FDA);    Direction-of-arrival (DOA);    Location deception;    Amplitude-comparison monopulse;   

DOI  :  10.1186/s13634-022-00890-3

来源: DOAJ

【 摘 要 】

Abstract Conventional phased array radar can direct the high-gain beam, resulting in high visibility under the reconnaissance system and even direct exposure to the enemy. As an amplitude-based direction-finding system, the amplitude monopulse system can recognize the traditional radar signals. However, there are still some issues with the countermeasures of the monopulse system, so it is necessary to find better styles of jamming. Since the beam of the frequency diverse array (FDA) signal at a certain angle varies with the range, we studied the deception effect of the FDA against the amplitude-comparison monopulse direction-finding system. By analyzing the established FDA-based direction-of-arrival location deception model against the amplitude-comparison monopulse system, we found that the introduction of the frequency increment might cause the FDA signals to deceit the monopulse system in principle. Then, to indicate the superiority of our deception method, we obtain the instantaneous signal-to-noise ratio, Cramér–Rao lower bound, root-means-square error, and variation. Numerical simulation results demonstrate that the FDA can generate deceptive signals to counteract the amplitude-comparison monopulse direction-finding system.

【 授权许可】

Unknown